CRA is a proud sponsor of the event.
Dan Donath is a panelist during the session titled “Innovation and Non-Price Competition” discussing:
- Evolution of practices on innovation and vertical integration
- Assessing innovation in pharma mergers
- Sustainability and merger control
- Labour markets and merger control?
- Different approaches in the EU (labour market issues addressed as antitrust infringements rather than in merger control) v US (Tapestry/Capri)
For more information on this event, click here.
